Advanced Clonal Agarwood Solutions by Crown Organogenesis Protocols Inc. (COPI)
Agaris™ is the flagship commercial plantlet brand of Crown Organogenesis Protocols Inc., specializing in tissue culture and organogenesis protocols for Aquilaria malaccensis and other high-value perfumery trees.
AGARIS™ Core Product Lines
1️⃣ Agaris™ Elite
Premium Clonal Agarwood Plantlets
Target Market:
Commercial plantation developers, agroforestry estates, institutional farms
Key Features:
- Tissue-cultured, genetically selected mother lines
- High resin-potential phenotype selection
- Uniform growth performance
- Disease-indexed material
- QR-based digital traceability ready
Product Forms:
- TC Plantlets (in vitro)
- Acclimatized Hardened Plantlets (4–6 months)
- Polybag-ready Field Transplants
Positioning:
High-performance planting material for export-grade agarwood production.
2️⃣ Agaris™ Prime
Commercial-Scale Clonal Production Line
Target Market:
Medium to large-scale growers seeking cost efficiency
Key Features:
- Standardized organogenesis-derived clones
- Stable growth rate
- Optimized for plantation uniformity
- Compatible with inoculation systems (e.g., Fusarium protocols)
Product Forms:
- Nursery-ready plantlets
- Bulk plantation supply contracts
Positioning:
Reliable and scalable agarwood planting material.
3️⃣ Agaris™ Genesis
Research & Institutional Grade Plantlets
Target Market:
Universities, R&D institutions, biotech laboratories
Key Features:
- Experimental clonal lines
- Controlled genotype batches
- Suitable for biochemical & extraction trials
- Small-batch precision propagation
Positioning:
Scientific-grade agarwood plant material for innovation and research.
4️⃣ Agaris™ Estate Packages
Integrated Plantation Starter Systems
Bundled solution including:
- Agaris™ Elite or Prime plantlets
- Planting layout design
- Agroforestry integration (e.g., sandalwood, nutmeg, elemi)
- Digital traceability integration
- Aftercare & technical consultancy
Ideal for:
- Investor-backed plantations
- Farm estate developments
- Academic-industry collaboration projects
🌿 Future Product Extensions (Pipeline)
🔬 Agaris™ CryoVault
Long-term germplasm conservation (cryopreservation program)
🌳 Agaris™ MultiSpecies Line
Tissue-cultured plantlets of:
- Sandalwood (Santalum album)
- Ylang-Ylang (Cananga odorata)
- Manila Elemi (Canarium luzonicum)
- Nutmeg (Myristica fragrans)
- Cinnamon (Cinnamomum verum)
Designed for integrated perfumery agroforestry systems.
🧬 Quality Assurance Framework
Agaris™ production is anchored on:
- Organogenesis-based micropropagation
- Mother tree phenotypic selection
- Controlled acclimatization protocols
- Pathogen screening
- Batch coding & digital traceability
💎 Brand Architecture Position
Crown Agri Group Inc.
→ Crown Organogenesis Protocols Inc. (COPI)
→ Agaris™ (Commercial Clonal Plantlets Brand)
Agaris™ serves as the biotech propagation arm supporting:
- Plantation companies
- Extraction companies
- Agroforestry developers
- Academic partnerships
🎯 Market Segments Served
- Commercial Agarwood Plantations
- Agroforestry Estates
- Export-Oriented Oud Producers
- Institutional Research Farms
- Government Reforestation Programs
If you’d like, I can now prepare:
- 📊 A pricing matrix per product line
- 📈 5-year production & revenue forecast
- 📄 Technical Product Specification Sheet (Investor Version)
- 🖼 Brand Portfolio Infographic
- 📦 Product Catalog Layout (print-ready brochure format)
Which format would you like to develop next for Agaris™?